Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent InhibitorsGiuseppe Campiani, Antje Prasse, Gabriele Carullo et al.|Journal of Medicinal Chemistry|2021Cited by 55
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological EvaluationA. Prasanth Saraswati, Giuseppe Campiani, Nicola Relitti et al.|ACS Medicinal Chemistry Letters|2020Cited by 44
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigationNicola Relitti, Giuseppe Campiani, A. Prasanth Saraswati et al.|European Journal of Medicinal Chemistry|2020Cited by 43
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viabilityStefano Federico, Giuseppe Campiani, Tuhina Khan et al.|European Journal of Medicinal Chemistry|2022Cited by 30
Screening and Phenotypical Characterization of <i>Schistosoma mansoni</i> Histone Deacetylase 8 (<i>Sm</i>HDAC8) Inhibitors as Multistage Antischistosomal AgentsFulvio Saccoccia, Giovina Ruberti, Margherita Brindisi et al.|ACS Infectious Diseases|2019Cited by 27